Skip to main content
. Author manuscript; available in PMC: 2013 Jun 8.
Published in final edited form as: Obesity (Silver Spring). 2010 Sep 9;19(4):729–735. doi: 10.1038/oby.2010.193

Table 3.

Multiple regression derived coefficients (b) and P values for vascular reactivity results

Flow-mediated
vasodilation
Nitroglycerin-
induced
vasodilation
Forearm resting
skin blood flow
Forearm post-
acetylcholine
blood flow
Forearm post-
sodium blood flow
b P value b P value b P value b P value b P value
Age −0.027 NS −0.021 NS 0.003 NS 0 NS 0.009 0.06
Gender
 Men vs. women −1.32 0.005 −1.43 0.06 0.03 NS −0.11 NS 0.04 NS
Studied groups
 LD vs. LC −1.68 NS −0.15 NS 0.02 NS 0 NS 0.31 0.09
 OC vs. LC −2.44 0.003 2.97 0.03 −0.18 0.04 −0.20 NS −0.23 NS
 OD vs. LC −2.09 0.04 −2.43 NS 0.07 NS 0 NS 0.15 NS
 OC vs. LD −0.75 NS 3.11 0.07 −0.19 0.05 −0.20 NS −0.54 0.001
 OD vs. LD −0.41 NS −2.29 0.02 0.01 NS 0 NS −0.16 0.06
 OD vs. OC 0.35 NS −5.39 0.001 0.20 0.04 0.20 NS 0.38 0.02
Antihypertensives
(ACE inhibitors and ARBs)
−1.20 0.04 −1.69 0.09 −0.02 NS 0.08 NS −0.09 NS
Oral antidiabetic treatment −0.43 NS 0.08 NS 0.05 NS 0.03 NS 0.11 NS
Insulin treatment −0.16 NS −1.29 NS 0.08 NS 0.03 NS −0.10 NS
Statin treatment 0.68 NS 1.44 NS −0.11 0.03 −0.09 NS −0.18 0.03

ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blockers; OC, obese controls; LC, nonobese controls; LD, nonobese DM patients.